Skip to main content

Table 4 Changes in MPO, NT-proBNP, and NLR level in VHD patients

From: Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease

 

MPO (mg/L)

NT-proBNP (ng/L)

NLR

I-II grade (n = 35)

102.37 ± 23.59

648.68 ± 128.09

5.35 ± 1.57

III-IV grade (n = 35)

171.47 ± 24.49

768.33 ± 154.89

6.63 ± 1.76

P

 < 0.001

0.007

0.014

  1. VHD Valvular Heart Disease, NT-proBNP N-terminus pro-brain natriuretic peptide, MPO Myeloperoxidase, NLR Neutrophil–Lymphocyte Ratio
Back to article page

Perioperative Medicine

ISSN: 2047-0525